Pages that link to "Q26783691"

The following pages link to Microparticles as Biomarkers of Blood Coagulation in Cancer (Q26783691):

Displaying 15 items.

• Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy (Q36390609) (← links)
• A review of the venous thrombotic issues associated with multiple myeloma (Q38845946) (← links)
• Microparticles as biomarkers of venous thromboembolic events (Q38874997) (← links)
• Extracellular vesicles and blood diseases (Q39107240) (← links)
• New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer (Q41283854) (← links)
• Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer. (Q42177895) (← links)
• Increased levels of circulating platelet-derived microparticles are associated with metastatic cutaneous melanoma. (Q43586264) (← links)
• Coagulation and fibrinolysis in gastric cancer (Q47916707) (← links)
• How to quantify microparticles in RBCs? A validated flow cytometry method allows the detection of an increase in microparticles during storage. (Q50217083) (← links)
• The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis. (Q52371201) (← links)
• Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer. (Q54967623) (← links)
• Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis (Q59806401) (← links)
• Coagulation in Brain Tumors: Biological Basis and Clinical Implications (Q64079735) (← links)
• Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms (Q88692135) (← links)
• Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma (Q99239295) (← links)